-
1.Process for the preparation of indazolyl ureas that inhibit Vanilloid subtype1 (VR1) receptors 有权
标题翻译: 制备抑制香草素亚型1(VR1)受体的吲唑基脲的方法公开(公告)号:US07847104B2
公开(公告)日:2010-12-07
申请号:US11734900
申请日:2007-04-13
申请人: Kirill A. Lukin , Margaret Chi-Ping Hsu , Dilinie P. Fernando , Brian J. Kotecki , Marvin R. Leanna
发明人: Kirill A. Lukin , Margaret Chi-Ping Hsu , Dilinie P. Fernando , Brian J. Kotecki , Marvin R. Leanna
IPC分类号: C07D231/56
CPC分类号: C07D231/56
摘要: The present invention relates to a process of preparing indazolyl ureas that are useful as antagonists of the vanilloid receptor subtype 1 (VR1).
摘要翻译: 本发明涉及制备可用作香草素受体亚型1(VR1)的拮抗剂的吲唑基脲的方法。
-
2.Process for the preparation of indazolyl ureas that inhibit Vanilloid subtype 1 (VR1) receptors 失效
标题翻译: 制备抑制香草素亚型1(VR1)受体的吲唑脲的方法公开(公告)号:US08519186B2
公开(公告)日:2013-08-27
申请号:US12914645
申请日:2010-10-28
申请人: Kirill A. Lukin , Margaret Chi-Ping Hsu , Dilinie P. Fernando , Brian J. Kotecki , Marvin R. Leanna
发明人: Kirill A. Lukin , Margaret Chi-Ping Hsu , Dilinie P. Fernando , Brian J. Kotecki , Marvin R. Leanna
IPC分类号: C07C275/26
CPC分类号: C07D231/56
摘要: The present invention relates to a process of preparing indazolyl ureas that are useful as antagonists of the vanilloid receptor subtype 1 (VR1).
摘要翻译: 本发明涉及制备可用作香草素受体亚型1(VR1)的拮抗剂的吲唑基脲的方法。
-
3.PROCESS FOR THE PREPARATION OF INDAZOLYL UREAS THAT INHIBIT VANILLOID SUBTYPE 1 (VR1) RECEPTORS 失效
标题翻译: 制备VANILLOID SUBTYPE 1(VR1)受体的非佐剂类URAAS的制备方法公开(公告)号:US20110040102A1
公开(公告)日:2011-02-17
申请号:US12914645
申请日:2010-10-28
申请人: Kirill A. Lukin , Margaret Chi-Ping Hsu , Dilinie P. Fernando , Brian J. Kotecki , Marvin R. Leanna
发明人: Kirill A. Lukin , Margaret Chi-Ping Hsu , Dilinie P. Fernando , Brian J. Kotecki , Marvin R. Leanna
IPC分类号: C07D231/56 , C07C275/26
CPC分类号: C07D231/56
摘要: The present invention relates to a process of preparing indazolyl ureas that are useful as antagonists of the vanilloid receptor subtype 1 (VR1).
摘要翻译: 本发明涉及制备可用作香草素受体亚型1(VR1)的拮抗剂的吲唑基脲的方法。
-
4.Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor 有权
标题翻译: 抑制香草素受体亚型1(VR1)受体的融合化合物公开(公告)号:US07375126B2
公开(公告)日:2008-05-20
申请号:US10864068
申请日:2004-06-09
申请人: Arthur R. Gomtsyan , Erol K. Bayburt , Chih-Hung Lee , John R. Koenig , Robert G. Schmidt , Kirill A. Lukin , Margaret Chi-Ping Hsu , Marvin R. Leanna , Russell D. Cink , Gilles Chambournier
发明人: Arthur R. Gomtsyan , Erol K. Bayburt , Chih-Hung Lee , John R. Koenig , Robert G. Schmidt , Kirill A. Lukin , Margaret Chi-Ping Hsu , Marvin R. Leanna , Russell D. Cink , Gilles Chambournier
IPC分类号: A61K31/403 , A61K31/416
CPC分类号: C07D217/02 , C07D231/56 , C07D401/12 , C07D401/14 , C07D403/12 , C07D413/12 , C07D417/12 , C07D471/08
摘要: The present invention discloses novel compounds of general formula (I) or a pharmaceutically acceptable salt or prodrug thereof (in which X1-X5, R5-R8b, Z1-Z2 and Ar1 are defined herein), a method for inhibiting the VR1 receptor in mammals using these compounds, a method for controlling pain in mammals, and pharmaceutical compositions including those compounds and a process for making those compounds.
摘要翻译: 本发明公开了通式(I)的新化合物或其药学上可接受的盐或前药(其中X 1,X 5,R 5, 本文中定义的方法,其中R 1,R 2,Z 2,Z 1,Z 2, 使用这些化合物抑制哺乳动物的VR1受体,抑制哺乳动物疼痛的方法,以及包括那些化合物的药物组合物和制备这些化合物的方法。
-
5.Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor 有权
标题翻译: 抑制香草素受体亚型1(VR1)受体的融合化合物公开(公告)号:US08071762B2
公开(公告)日:2011-12-06
申请号:US12112105
申请日:2008-04-30
申请人: Arthur R. Gomtsyan , Erol K. Bayburt , Chih-Hung Lee , John R. Koenig , Robert G. Schmidt , Kirill A. Lukin , Gilles Chambournier , Margaret Chi-Ping Hsu , Marvin R. Leanna , Russell D. Cink
发明人: Arthur R. Gomtsyan , Erol K. Bayburt , Chih-Hung Lee , John R. Koenig , Robert G. Schmidt , Kirill A. Lukin , Gilles Chambournier , Margaret Chi-Ping Hsu , Marvin R. Leanna , Russell D. Cink
IPC分类号: C07D401/02 , C07D231/56
CPC分类号: C07D231/56 , C07D217/02 , C07D401/12 , C07D403/12
摘要: The present invention discloses novel compounds of general formula (I) or a pharmaceutically acceptable salt or prodrug thereof (in which X1-X5, R5-R8b, Z1-Z2 and Ar1 are defined herein), a method for inhibiting the VR1 receptor in mammals using these compounds, a method for controlling pain in mammals, and pharmaceutical compositions including those compounds and a process for making those compounds.
摘要翻译: 本发明公开了通式(I)的新化合物或其药学上可接受的盐或前药(其中X1-X5,R5-R8b,Z1-Z2和Ar1如本文所定义),哺乳动物中抑制VR1受体的方法 使用这些化合物,控制哺乳动物疼痛的方法,以及包含那些化合物的药物组合物和制备这些化合物的方法。
-
-
-
-